• Skills People And Talent

Stevenage Bioscience Catalyst strengthens Board with appointment of two new Non-Executive Directors

Clare Terlouw, Head of Corporate Development at Syncona Investment Management Limited and Jon Green, Chair of One Nucleus, will be joining the SBC Board on 1st October 2019.

Repositive appoints Slaven Stekovic as Head of Strategic Growth and leading commercial advisers to drive the company’s scale-up and global growth ambitions

Repositive – the Cambridge-based startup that connects researchers with the right preclinical cancer models for their research – today announced the appointment of Slaven Stekovic as Head of Strategic Growth, along with leading commercial experts (Mariana Vaschetto and Francesca Crawford) to its advisory board, to drive the company’s scale-up and global growth ambitions within the pharma and biotech market.

Coulter Partners secures Non-Executive Director for Nanoform

Coulter Partners was very pleased to partner once more with innovative medicine enabling nanotechnology company, Nanoform to secure the appointment of Mads Laustsen as a non-executive board member. This appointment will further strengthen the experienced Nanoform board and support the company as it increases its ability to deliver nanonized APIs for global partners across the pipeline from late stage drug discovery to commercial.

Locate Bio appoints John van Benecke as CFO and COO

Locate Bio has appointed John van Benecke as CFO and COO as the company focuses on developing its innovative cell and gene therapy pipeline out of leading research from the University of Nottingham

James Keeling, new Chief Financial Officer at Stevenage Bioscience Catalyst

Stevenage Bioscience Catalyst (SBC), a leading location for development and commercialisation of cutting-edge therapeutics, is pleased to announce that James Keeling has been appointed as Chief Financial Officer (CFO).

Dr. Philip Beer joins CCG.ai

Dr. Philip Beer joins Cambridge Cancer Genomics as Head of Translational Medicine

Global Head of Neuroscience Discovery marks the official launch of The Biosphere

On Thursday 4 July Dr. Fiona Marshall, Global Head of Neuroscience Discovery, MSD visited Newcastle to mark the official launch of The Biosphere.

Cancer vaccine firm Oxford Vacmedix announces collaboration and Innovate UK grant

CHAIN Biotechnology and University of Oxford have been awarded grant funding to develop live biotherapeutics that support oral delivery of Oxford Vacmedix’s immunotherapy cancer vaccines.

Theolytics Limited comes out of stealth mode with Dr Ken Powell announced as Chair of the Board

We're thrilled to announce the appointment of Dr Ken Powell as Chair to the Board of Directors for Theolytics. Ken brings extensive virology and commercial expertise, including from founding roles at Arrow Therapeutics and Reviral.

Medherant positions itself for the next stage of its development with the appointment of a new CEO

Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019. Nigel Davis, the current CEO, will remain with the Company as Chief Business Officer.